Industry Research Reports

Home > Reports > Service & Software > Global Sepsis Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Sepsis Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-09-06

Pages: 77 Pages

Report ld: 5000072

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Sepsis Therapeutics Market Size(US$)

CAGR 2025-2031

6.7%

Market Size,2031

USD 5,991

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,060 million

Market Forecast in 2031(Value)

US$ 5,991 million

CAGR

6.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Sepsis Therapeutics market size was US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Sepsis Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Agennix
AstraZeneca
Atox Bio
CytoGenix
Eli Lilly
Endacea
NexBio
Medinox

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Aminoglycosides
Colony Stimulating Factors
Second Generation Cephalosporins
Third Generation Cephalosporins
Glycopeptide Antibiotics
Inhaled Intifectives
Others

Segment by Application

Hospitals
Clinics
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Sepsis Therapeutics market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Colony Stimulating Factors in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Sepsis Therapeutics value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Aminoglycosides

1.2.3 Colony Stimulating Factors

1.2.4 Second Generation Cephalosporins

1.2.5 Third Generation Cephalosporins

1.2.6 Glycopeptide Antibiotics

1.2.7 Inhaled Intifectives

1.2.8 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sepsis Therapeutics Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Sepsis Therapeutics Revenue Market Share by Region (2020-2025)

2.4 Global Sepsis Therapeutics Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.2 Europe Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.3 China Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.4 Japan Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.5 Southeast Asia Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.6 India Sepsis Therapeutics Market Size and Prospective (2020-2031)

2.5.7 Central & South America Sepsis Therapeutics Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Sepsis Therapeutics Historic Market Size by Type (2020-2025)

3.2 Global Sepsis Therapeutics Forecasted Market Size by Type (2026-2031)

3.3 Different Types Sepsis Therapeutics Representative Players

4 Breakdown Data by Application

4.1 Global Sepsis Therapeutics Historic Market Size by Application (2020-2025)

4.2 Global Sepsis Therapeutics Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Sepsis Therapeutics Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Sepsis Therapeutics Players by Revenue (2020-2025)

5.1.2 Global Sepsis Therapeutics Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Sepsis Therapeutics Revenue

5.4 Global Sepsis Therapeutics Market Concentration Analysis

5.4.1 Global Sepsis Therapeutics Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Sepsis Therapeutics Revenue in 2024

5.5 Global Key Players of Sepsis Therapeutics Head office and Area Served

5.6 Global Key Players of Sepsis Therapeutics, Product and Application

5.7 Global Key Players of Sepsis Therapeutics, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Sepsis Therapeutics Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Sepsis Therapeutics Market Size by Type (2020-2025)

6.1.2.2 North America Sepsis Therapeutics Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Sepsis Therapeutics Market Size by Application (2020-2025)

6.1.3.2 North America Sepsis Therapeutics Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Sepsis Therapeutics Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Sepsis Therapeutics Market Size by Type (2020-2025)

6.2.2.2 Europe Sepsis Therapeutics Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Sepsis Therapeutics Market Size by Application (2020-2025)

6.2.3.2 Europe Sepsis Therapeutics Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Sepsis Therapeutics Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Sepsis Therapeutics Market Size by Type (2020-2025)

6.3.2.2 China Sepsis Therapeutics Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Sepsis Therapeutics Market Size by Application (2020-2025)

6.3.3.2 China Sepsis Therapeutics Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Sepsis Therapeutics Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Sepsis Therapeutics Market Size by Type (2020-2025)

6.4.2.2 Japan Sepsis Therapeutics Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Sepsis Therapeutics Market Size by Application (2020-2025)

6.4.3.2 Japan Sepsis Therapeutics Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 Southeast Asia Market: Players, Segments and Downstream

6.5.1 Southeast Asia Sepsis Therapeutics Revenue by Company (2020-2025)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Sepsis Therapeutics Market Size by Type (2020-2025)

6.5.2.2 Southeast Asia Sepsis Therapeutics Market Share by Type (2020-2025)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Sepsis Therapeutics Market Size by Application (2020-2025)

6.5.3.2 Southeast Asia Sepsis Therapeutics Market Share by Application (2020-2025)

6.5.4 Southeast Asia Market Trend and Opportunities

6.6 India Market: Players, Segments and Downstream

6.6.1 India Sepsis Therapeutics Revenue by Company (2020-2025)

6.6.2 India Market Size by Type

6.6.2.1 India Sepsis Therapeutics Market Size by Type (2020-2025)

6.6.2.2 India Sepsis Therapeutics Market Share by Type (2020-2025)

6.6.3 India Market Size by Application

6.6.3.1 India Sepsis Therapeutics Market Size by Application (2020-2025)

6.6.3.2 India Sepsis Therapeutics Market Share by Application (2020-2025)

6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Agennix

7.1.1 Agennix Company Details

7.1.2 Agennix Business Overview

7.1.3 Agennix Sepsis Therapeutics Introduction

7.1.4 Agennix Revenue in Sepsis Therapeutics Business (2020-2025)

7.1.5 Agennix Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Details

7.2.2 AstraZeneca Business Overview

7.2.3 AstraZeneca Sepsis Therapeutics Introduction

7.2.4 AstraZeneca Revenue in Sepsis Therapeutics Business (2020-2025)

7.2.5 AstraZeneca Recent Development

7.3 Atox Bio

7.3.1 Atox Bio Company Details

7.3.2 Atox Bio Business Overview

7.3.3 Atox Bio Sepsis Therapeutics Introduction

7.3.4 Atox Bio Revenue in Sepsis Therapeutics Business (2020-2025)

7.3.5 Atox Bio Recent Development

7.4 CytoGenix

7.4.1 CytoGenix Company Details

7.4.2 CytoGenix Business Overview

7.4.3 CytoGenix Sepsis Therapeutics Introduction

7.4.4 CytoGenix Revenue in Sepsis Therapeutics Business (2020-2025)

7.4.5 CytoGenix Recent Development

7.5 Eli Lilly

7.5.1 Eli Lilly Company Details

7.5.2 Eli Lilly Business Overview

7.5.3 Eli Lilly Sepsis Therapeutics Introduction

7.5.4 Eli Lilly Revenue in Sepsis Therapeutics Business (2020-2025)

7.5.5 Eli Lilly Recent Development

7.6 Endacea

7.6.1 Endacea Company Details

7.6.2 Endacea Business Overview

7.6.3 Endacea Sepsis Therapeutics Introduction

7.6.4 Endacea Revenue in Sepsis Therapeutics Business (2020-2025)

7.6.5 Endacea Recent Development

7.7 NexBio

7.7.1 NexBio Company Details

7.7.2 NexBio Business Overview

7.7.3 NexBio Sepsis Therapeutics Introduction

7.7.4 NexBio Revenue in Sepsis Therapeutics Business (2020-2025)

7.7.5 NexBio Recent Development

7.8 Medinox

7.8.1 Medinox Company Details

7.8.2 Medinox Business Overview

7.8.3 Medinox Sepsis Therapeutics Introduction

7.8.4 Medinox Revenue in Sepsis Therapeutics Business (2020-2025)

7.8.5 Medinox Recent Development

8 Sepsis Therapeutics Market Dynamics

8.1 Sepsis Therapeutics Industry Trends

8.2 Sepsis Therapeutics Market Drivers

8.3 Sepsis Therapeutics Market Challenges

8.4 Sepsis Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Sepsis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Sepsis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Sepsis Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Sepsis Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Sepsis Therapeutics Revenue Share by Region (2020-2025)

Table 6. Global Sepsis Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Sepsis Therapeutics Revenue Share Forecast by Region (2026-2031)

Table 8. Global Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Sepsis Therapeutics Revenue Market Share by Type (2020-2025)

Table 10. Global Sepsis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Sepsis Therapeutics Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Sepsis Therapeutics Revenue Market Share by Application (2020-2025)

Table 15. Global Sepsis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Sepsis Therapeutics Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Sepsis Therapeutics Application

Table 18. Global Sepsis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Sepsis Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Sepsis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2024)

Table 21. Ranking of Global Top Sepsis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Sepsis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Sepsis Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Sepsis Therapeutics, Product and Application

Table 25. Global Key Players of Sepsis Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 29. North America Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 33. Europe Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 37. China Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 41. Japan Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Sepsis Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Sepsis Therapeutics Revenue Market Share by Company (2020-2025)

Table 49. India Sepsis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Sepsis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 51. Agennix Company Details

Table 52. Agennix Business Overview

Table 53. Agennix Sepsis Therapeutics Product

Table 54. Agennix Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Agennix Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Sepsis Therapeutics Product

Table 59. AstraZeneca Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Atox Bio Company Details

Table 62. Atox Bio Business Overview

Table 63. Atox Bio Sepsis Therapeutics Product

Table 64. Atox Bio Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Atox Bio Recent Development

Table 66. CytoGenix Company Details

Table 67. CytoGenix Business Overview

Table 68. CytoGenix Sepsis Therapeutics Product

Table 69. CytoGenix Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 70. CytoGenix Recent Development

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Sepsis Therapeutics Product

Table 74. Eli Lilly Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Eli Lilly Recent Development

Table 76. Endacea Company Details

Table 77. Endacea Business Overview

Table 78. Endacea Sepsis Therapeutics Product

Table 79. Endacea Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Endacea Recent Development

Table 81. NexBio Company Details

Table 82. NexBio Business Overview

Table 83. NexBio Sepsis Therapeutics Product

Table 84. NexBio Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 85. NexBio Recent Development

Table 86. Medinox Company Details

Table 87. Medinox Business Overview

Table 88. Medinox Sepsis Therapeutics Product

Table 89. Medinox Revenue in Sepsis Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Medinox Recent Development

Table 91. Sepsis Therapeutics Market Trends

Table 92. Sepsis Therapeutics Market Drivers

Table 93. Sepsis Therapeutics Market Challenges

Table 94. Sepsis Therapeutics Market Restraints

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Sepsis Therapeutics Product Picture

Figure 2. Global Sepsis Therapeutics Market Share by Type: 2024 VS 2031

Figure 3. Aminoglycosides Features

Figure 4. Colony Stimulating Factors Features

Figure 5. Second Generation Cephalosporins Features

Figure 6. Third Generation Cephalosporins Features

Figure 7. Glycopeptide Antibiotics Features

Figure 8. Inhaled Intifectives Features

Figure 9. Others Features

Figure 10. Global Sepsis Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Other

Figure 14. Sepsis Therapeutics Report Years Considered

Figure 15. Global Sepsis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Sepsis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Sepsis Therapeutics Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Europe Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. China Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Japan Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Southeast Asia Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. India Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Central & South America Sepsis Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Global Sepsis Therapeutics Market Share by Players in 2024

Figure 26. Global Top Sepsis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2024)

Figure 27. The Top 10 and 5 Players Market Share by Sepsis Therapeutics Revenue in 2024

Figure 28. North America Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 29. North America Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 30. Europe Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 31. Europe Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 32. China Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 33. China Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 34. Japan Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 35. Japan Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 36. Southeast Asia Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 37. Southeast Asia Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 38. India Sepsis Therapeutics Market Share by Type (2020-2025)

Figure 39. India Sepsis Therapeutics Market Share by Application (2020-2025)

Figure 40. Agennix Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 41. AstraZeneca Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 42. Atox Bio Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 43. CytoGenix Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 44. Eli Lilly Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 45. Endacea Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 46. NexBio Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 47. Medinox Revenue Growth Rate in Sepsis Therapeutics Business (2020-2025)

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Sepsis Therapeutics in 2031? shouQi

What was the global market size of Sepsis Therapeutics in 2025? shouQi

Which companies rank high in the global Sepsis Therapeutics market? shouQi

What is the annual compound growth rate of the global Sepsis Therapeutics market size from 2025 to 2031? shouQi

Related Reports

Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sepsis Therapeutics was estimated to be worth US$ 4060 million in 2025 and is projected to reach US$ 6352 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 103
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Market Research Report 2026
The global Sepsis Therapeutics market was valued at US$ 4060 million in 2025 and is anticipated to reach US$ 6352 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 107
USD 2900.00
(Single User License)
Global Sepsis Therapeutics Market Research Report 2025
The global market for Sepsis Therapeutics was valued at US$ 3829 million in the year 2024 and is projected to reach a revised size of US$ 5991 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-27
Pages: 72
USD 2900.00
(Single User License)
Sepsis Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sepsis Therapeutics was estimated to be worth US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 87
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Market Insights, Forecast to 2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-04-25
Pages: 93
USD 4900.00
(Single User License)
Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-01-24
Pages: 80
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Market Research Report 2024
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)

Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sepsis Therapeutics was estimated to be worth US$ 4060 million in 2025 and is projected to reach US$ 6352 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-15
Pages: 103
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Market Research Report 2026
The global Sepsis Therapeutics market was valued at US$ 4060 million in 2025 and is anticipated to reach US$ 6352 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-28
Pages: 107
USD 2900.00 (Single User License)
Global Sepsis Therapeutics Market Research Report 2025
The global market for Sepsis Therapeutics was valued at US$ 3829 million in the year 2024 and is projected to reach a revised size of US$ 5991 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-27
Pages: 72
USD 2900.00 (Single User License)
Sepsis Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sepsis Therapeutics was estimated to be worth US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 87
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Market Insights, Forecast to 2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-04-25
Pages: 93
USD 4900.00 (Single User License)
Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-01-24
Pages: 80
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Market Research Report 2024
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)